Novacyt
Peter Coyne is a results-oriented executive with over 25 years of experience in operations and quality management. Currently serving as the Chief Operations Officer at Novacyt since November 2021, Peter previously held the position of Industrial Operations Director at DiaSorin from September 2017 to November 2021. Additional roles include Group Head of Operations at EKF Diagnostics, General Manager at Owen Mumford Ltd, and Manufacturing Manager at Abbott Diabetes Care. Peter holds a BA (Hons) in Business and a Diploma in Economics from the Open University.
This person is not in any teams
This person is not in any offices
Novacyt
2 followers
The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths liein diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units comprise of Primerdesign andLab21 Products,supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology andserology markets as do its global partners, which include major corporates.